AbCellera Biologics Inc. (ABCL)

AbCellera Biologics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 3, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,054	865	1,657	2,898	4,027	10,832
Market Cap Growth	21.34%	-47.77%	-42.83%	-28.02%	-62.83%	-
Enterprise Value	700	294	952	2,106	3,305	10,829
Last Close Price	3.52	2.93	5.71	10.13	14.30	40.24
PE Ratio	-	-	-	18.28	26.24	127.29
Forward PE	-	-	-	-	51.81	-
PS Ratio	29.66	30.02	43.57	5.97	10.73	46.46
PB Ratio	1.09	0.82	1.44	2.35	3.93	13.04
P/TBV Ratio	1.20	0.90	1.68	2.75	4.85	15.84
P/FCF Ratio	-	-	-	14.02	21.63	832.15
P/OCF Ratio	-	-	-	10.45	16.46	477.40
EV/Sales Ratio	19.82	10.19	25.03	4.34	8.81	46.45
EV/EBITDA Ratio	-	-	-	8.62	15.10	67.32
EV/EBIT Ratio	-	-	-	9.36	16.17	69.40
EV/FCF Ratio	-	-	-	10.19	17.76	831.92
Debt / Equity Ratio	0.15	0.06	0.07	0.07	0.04	0.01
Debt / EBITDA Ratio	-	-	-	0.32	0.18	0.03
Debt / FCF Ratio	-	-	-	0.40	0.22	0.34
Asset Turnover	0.03	0.02	0.03	0.34	0.32	0.45
Inventory Turnover	-	-	-	108.81	69.86	71.97
Quick Ratio	8.49	8.95	6.93	8.37	7.44	7.81
Current Ratio	10.10	9.81	7.33	8.67	7.71	7.86
Return on Equity (ROE)	-16.81%	-14.75%	-12.27%	14.03%	16.54%	28.29%
Return on Assets (ROA)	-10.43%	-12.41%	-9.79%	9.83%	10.99%	18.95%
Return on Invested Capital (ROIC)	-38.00%	-58.61%	-52.82%	38.64%	49.05%	93.91%
Return on Capital Employed (ROCE)	-17.80%	-22.00%	-17.30%	15.80%	17.10%	17.30%
Earnings Yield	-16.29%	-18.82%	-8.84%	5.47%	3.81%	1.10%
FCF Yield	-14.53%	-21.60%	-7.29%	7.13%	4.62%	0.12%
Buyback Yield / Dilution	-1.57%	-1.79%	8.15%	1.09%	-20.96%	-73.88%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q